CN113577249A - Method and process for making compound medicinal food for reducing high blood pressure, high blood sugar and high blood sugar - Google Patents
Method and process for making compound medicinal food for reducing high blood pressure, high blood sugar and high blood sugar Download PDFInfo
- Publication number
- CN113577249A CN113577249A CN202110954950.8A CN202110954950A CN113577249A CN 113577249 A CN113577249 A CN 113577249A CN 202110954950 A CN202110954950 A CN 202110954950A CN 113577249 A CN113577249 A CN 113577249A
- Authority
- CN
- China
- Prior art keywords
- extract
- blood
- high blood
- preparation
- reducing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008280 blood Substances 0.000 title claims abstract description 85
- 210000004369 blood Anatomy 0.000 title claims abstract description 84
- 238000000034 method Methods 0.000 title claims abstract description 18
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 17
- 150000001875 compounds Chemical class 0.000 title claims abstract description 17
- 230000008569 process Effects 0.000 title claims description 12
- 235000013305 food Nutrition 0.000 title claims description 8
- 239000000284 extract Substances 0.000 claims abstract description 67
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 11
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 11
- 235000005911 diet Nutrition 0.000 claims abstract description 11
- 230000037213 diet Effects 0.000 claims abstract description 11
- 240000002045 Guettarda speciosa Species 0.000 claims abstract description 10
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 10
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 9
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 9
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 9
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 9
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 9
- 241000756042 Polygonatum Species 0.000 claims abstract description 9
- 229940094952 green tea extract Drugs 0.000 claims abstract description 9
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 9
- 244000164480 Curcuma aromatica Species 0.000 claims abstract description 7
- 235000003398 Curcuma aromatica Nutrition 0.000 claims abstract description 7
- 102000004190 Enzymes Human genes 0.000 claims abstract description 5
- 108090000790 Enzymes Proteins 0.000 claims abstract description 5
- 239000009724 Salvia extract Substances 0.000 claims abstract description 4
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 229910001220 stainless steel Inorganic materials 0.000 claims abstract description 4
- 239000010935 stainless steel Substances 0.000 claims abstract description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 9
- 230000036772 blood pressure Effects 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 230000010355 oscillation Effects 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 241000304195 Salvia miltiorrhiza Species 0.000 claims description 5
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims description 5
- 235000012000 cholesterol Nutrition 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 240000008042 Zea mays Species 0.000 claims description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 3
- 239000006286 aqueous extract Substances 0.000 claims description 3
- 235000005822 corn Nutrition 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 239000011812 mixed powder Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 62
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 10
- 210000004204 blood vessel Anatomy 0.000 abstract description 9
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 9
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 8
- 230000003647 oxidation Effects 0.000 abstract description 6
- 238000007254 oxidation reaction Methods 0.000 abstract description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract description 6
- 235000013824 polyphenols Nutrition 0.000 abstract description 6
- 210000003743 erythrocyte Anatomy 0.000 abstract description 5
- 239000003053 toxin Substances 0.000 abstract description 5
- 231100000765 toxin Toxicity 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 229930182490 saponin Natural products 0.000 abstract description 4
- 235000017709 saponins Nutrition 0.000 abstract description 4
- 150000007949 saponins Chemical class 0.000 abstract description 4
- 210000000170 cell membrane Anatomy 0.000 abstract description 2
- 229930003935 flavonoid Natural products 0.000 abstract description 2
- 235000017173 flavonoids Nutrition 0.000 abstract description 2
- 150000002215 flavonoids Chemical class 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 210000004185 liver Anatomy 0.000 description 18
- 208000002193 Pain Diseases 0.000 description 16
- 244000269722 Thea sinensis Species 0.000 description 14
- 230000017531 blood circulation Effects 0.000 description 14
- 230000001737 promoting effect Effects 0.000 description 14
- 230000007812 deficiency Effects 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 11
- 230000002401 inhibitory effect Effects 0.000 description 11
- 208000031226 Hyperlipidaemia Diseases 0.000 description 10
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 235000013616 tea Nutrition 0.000 description 10
- 201000001421 hyperglycemia Diseases 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 8
- 208000002173 dizziness Diseases 0.000 description 7
- 230000004438 eyesight Effects 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- -1 oxygen radicals Chemical class 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 208000037093 Menstruation Disturbances Diseases 0.000 description 4
- 206010027339 Menstruation irregular Diseases 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 208000031971 Yin Deficiency Diseases 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 229910052796 boron Inorganic materials 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 235000005487 catechin Nutrition 0.000 description 4
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 4
- 229950001002 cianidanol Drugs 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 235000009569 green tea Nutrition 0.000 description 4
- 208000013403 hyperactivity Diseases 0.000 description 4
- 210000005229 liver cell Anatomy 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 108700012359 toxins Proteins 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 206010021143 Hypoxia Diseases 0.000 description 3
- 229930183118 Tanshinone Natural products 0.000 description 3
- 206010047513 Vision blurred Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 208000031225 myocardial ischemia Diseases 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- HYXITZLLTYIPOF-UHFFFAOYSA-N 1,6,6-trimethyl-8,9-dihydro-7H-naphtho[1,2-g]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)=CO2 HYXITZLLTYIPOF-UHFFFAOYSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 206010013789 Dry throat Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 208000032139 Halitosis Diseases 0.000 description 2
- 208000004044 Hypesthesia Diseases 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010023644 Lacrimation increased Diseases 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 208000032912 Local swelling Diseases 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 229940093797 bioflavonoids Drugs 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000010307 cell transformation Effects 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- TVZPLCNGKSPOJA-UHFFFAOYSA-N copper zinc Chemical compound [Cu].[Zn] TVZPLCNGKSPOJA-UHFFFAOYSA-N 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000020764 fibrinolysis Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 230000004317 lacrimation Effects 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- 239000011733 molybdenum Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 210000002254 renal artery Anatomy 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/446—Superoxide dismutase (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y115/00—Oxidoreductases acting on superoxide as acceptor (1.15)
- C12Y115/01—Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
- C12Y115/01001—Superoxide dismutase (1.15.1.1)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Abstract
The invention discloses a method and a process for preparing a compound medicinal diet for reducing high blood pressure, high blood sugar and high blood sugar, which comprises the following steps: step 1: taking 0.8g of chrysanthemum extract, 0.4g of angelica extract, 0.5g of polygonatum extract, 2g of green tea extract, 0.8g of wolfberry extract, 0.4g of salvia extract, 0.3g of curcuma aromatica extract and 0.8g of gynostemma pentaphylla extract, mixing uniformly, and putting all the components in a stainless steel granulator for later use. Has the advantages that: the invention can effectively remove blood stasis and activate blood, disperse aggregated red blood cells, remove garbage and dirt adhered to the vessel wall, dissolve and remove toxin, dredge the blood vessel, protect the cell membrane from oxidation, has extremely obvious dietotherapy effect and simultaneously reduces the occurrence of serious cardiovascular and cerebrovascular diseases through the synergistic action of a plurality of flavonoids, polyphenols, saponins and other compounds in the medicinal diet and a plurality of functional enzymes.
Description
Technical Field
The invention relates to the technical field of medicated food, in particular to a method and a process for preparing a compound three-high reducing medicated diet.
Background
At present, the people suffering from cardiovascular and cerebrovascular diseases in China reach hundreds of millions of people, the number of people suffering from hypertension, hyperlipidemia and hyperglycemia is broken through by 2 billion people, the progressive increase fleet of the cardiovascular and cerebrovascular diseases is the people suffering from hypertension, hyperlipidemia and hyperglycemia, and the occurrence of the cardiovascular and cerebrovascular diseases is closely related to the factors such as red blood cell accumulation of various tissues and organs of a human body, excessive greasiness of food, excessive oxygen radicals and the like; when the human body is low in immunity and blocked due to deficiency of both qi and blood, a plurality of red blood cells are gathered together to form an adherent group, so that capillary vessels can be blocked, microcirculation disturbance is caused, cells and various tissues and organs are ischemic, hypoxia is caused to be pathological, symptoms such as blood viscosity, hypertension, hyperlipidemia, high blood viscosity and the like are caused, the immunocompetence of the blood vessels is reduced, dead red blood cells cannot be removed in time, triglyceride and low-density lipoprotein are gathered and adhered to the positions of aorta, coronary artery, renal artery and the like, tissue necrosis is caused, serious diseases such as cerebral thrombosis, cerebral infarction, cerebral hemorrhage, senile dementia and the like are caused, the blood vessels are accelerated to age, the blood vessels become hard and brittle, the lumens are narrowed, the blood and oxygen supply capacity is weakened, and system symptoms such as myocardial ischemia, cerebral ischemia, chest distress and short breath, dizziness and headache, nausea are caused, serious can be life threatening.
At present, various medicines for treating cardiovascular and cerebrovascular diseases are abundant, the treatment effects of different degrees of stratification are obtained, and various health-care foods for preventing hypertension, hyperlipidemia and hyperglycemia have good effects, but have many defects, such as unreasonable formula, low effect of reducing hypertension, hyperlipidemia and hyperglycemia, effective use and repeated stop, so that the problem that the medicines can be taken for life to inhibit the hypertension, hyperlipidemia and hyperglycemia, blood and vascular wall garbage toxic scale cannot be effectively removed, and the like, and the technical problems are still prominent.
Disclosure of Invention
The invention aims to solve the problems and provide a preparation method and a process of a compound medicinal diet for reducing high blood pressure, high blood sugar and high blood sugar.
The invention realizes the purpose through the following technical scheme:
the preparation method of the compound medicinal diet for reducing high blood pressure, high blood sugar and the process thereof comprise the following steps:
step 1: taking 0.8g of chrysanthemum extract, 0.4g of angelica extract, 0.5g of polygonatum extract, 2g of green tea extract, 0.8g of wolfberry extract, 0.4g of salvia extract, 0.3g of curcuma aromatica extract and 0.8g of gynostemma pentaphylla extract, mixing uniformly, and putting all the components into a stainless steel granulator for later use;
step 2: putting 1g of the mixed powder and 30mg of SOD into a 100ml triangular flask, injecting 3ml of magnetized water with the temperature of 40 ℃, fully stirring uniformly, and putting into an ultrasonic oscillator with the temperature of-40 HZ for ultrasonic oscillation for 20 minutes;
and step 3: pouring the mixed liquid medicine after ultrasonic oscillation into a small-sized sprayer, starting a granulator, spraying inwards while rotating, stopping the machine when the liquid medicine is sprayed out and the mixed extract medicinal powder is irregularly granular, taking out, and drying in a constant-temperature drying oven at 40 ℃;
and 4, step 4: taking out the dried granules when the water content is below 3%, cooling, filling 2g of the dried granules into each bag, and vacuum sealing to obtain the medicated food for reducing blood fat, blood pressure and cholesterol.
Further, the chrysanthemum extract, the angelica extract, the polygonatum extract, the green tea extract, the wolfberry extract, the salvia miltiorrhiza extract, the curcuma aromatica extract and the gynostemma pentaphylla extract in the step 1 are all aqueous extracts.
Further, the ratio of raw materials to extract in each extract in the step 1 is 50: 1.
Further, the SOD in the step 2 is a functional enzyme extracted from corn by a pure physical process method, and the SOD has the main characteristics that: SOD belongs to copper zinc type (cu, zn-SOD), is a water-soluble protease, the molecular weight is about 32KD, the half-life period is 72 hours, dry for 36 months at normal temperature, basically non-inactivation, the activity is 3000IU/mg, white powder, SOD has stronger ability of resisting hydrolysis of pepsin and trypsin, its super-strong activity has super-ordinary scavenging action to superoxide anion free radical and various toxins in human body, has extremely important function in preventing the oxidation of oxygen free radical to normal cell, resisting radiation damage and reducing cell variation and cell transformation cancer of variant cell.
Furthermore, the chrysanthemum extract has the effects of dispelling wind, dissipating heat, detoxifying and improving eyesight, is used for treating conjunctival congestion, swelling and pain, dim eyes, wind and lacrimation caused by wind heat of liver channels or liver fire hyperactivity, is used for treating dizziness caused by liver wind, upward disturbance and liver yang hyperactivity, and also has a good inhibition effect on staphylococcus, streptococcus, pseudomonas aeruginosa, dysentery bacillus and other pathogenic bacteria, and particularly has an outstanding antipyretic and antihypertensive effect; the angelica extract has the effects of enriching blood, regulating menstruation, promoting blood circulation, relieving pain, relaxing bowel, treating dizziness, dim eyesight, palpitation, fatigue and weakness caused by blood deficiency and blood deficiency, treating irregular menstruation caused by blood deficiency, treating abdominal pain, blood stasis pain, arthralgia and numbness caused by blood deficiency, treating constipation caused by blood deficiency and the like, has the functions of breaking blood, promoting blood circulation and nourishing blood, and has the functions of easing pain, calming, protecting liver and preventing reduction of glycogen; the polygonatum extract has the effects of nourishing yin, moistening lung, promoting fluid production and nourishing stomach, is used for dry throat, thirst and cough caused by dryness heat of lung and stomach, is used for body fluid deficiency caused by heat injury of stomach yin and the like, and has a better improvement effect on myocardial ischemia.
Furthermore, the green tea extract contains catechin, tea polyphenol, tea pigment, vitamins such as VC and VP and a plurality of mineral compositions, the vitamins and the catechin in the green tea can effectively enhance the flexibility and the elasticity of blood vessels, have the effects of resisting platelet aggregation, promoting fibrinolysis and lowering blood pressure, are particularly beneficial to preventing and treating cardiovascular and cerebrovascular diseases, have the effects of resisting oxidation, resisting radiation and improving immunity, have definite anti-cancer and cancer-prevention effects, the tea polyphenol has the effects of preventing caries and strengthening teeth, small molecular compounds in the tea pigment have the effects of dissolving fat, low-density cholesterol and triglyceride in blood and preventing the accumulation of fat in liver, caffeine and small molecular aromatic substances in the tea have the excitation effect, can promote the excitation and the strengthening of brain heartbeat, quickening blood flow, increasing digestive juice and enhancing the urine filtering function of glomeruli, also has antiallergic, antibacterial, antiviral, toxic substance removing, and halitosis eliminating effects, which is the main reason for reducing hypertension, hyperlipidemia and hyperglycemia by using various compounds in green tea.
Furthermore, the wolfberry fruit extract has the effects of nourishing liver and kidney, improving eyesight and moistening lung, is used for dizziness, blurred vision, poor eyesight, soreness and weakness of waist and knees, spermatorrhea, thirst quenching and the like caused by liver-kidney yin deficiency, is used for cough due to yin deficiency, little phlegm or no phlegm and the like, contains carotene, vitamin B, B, C, linoleic acid and the like, has the effect of reducing blood sugar, can inhibit fat deposition in liver cells and promote liver cell regeneration, and also has the effect of reducing blood cholesterol.
Furthermore, the salvia miltiorrhiza extract has the effects of promoting blood circulation to remove blood stasis, cooling blood to relieve pain, nourishing blood and soothing nerves, can be used for treating amenorrhea due to blood stagnation, puerperal abdominal distention and pain, and for treating sore and carbuncle with swelling and pain, local swelling and fever due to excessive toxic heat, can be used for treating hyperpyrexia, dysphoria or macula caused by warm disease heat entering nutrient-blood, Saviae Miltiorrhizae radix is slightly cold in nature, has effects of removing blood stasis more than blood, and can remove blood stasis to promote tissue regeneration, so can also promote generation of new blood, but the efficacy of enriching the blood is not as good as that of angelica, the medicine contains tanshinone A, tanshinone B, tanshinone C, salvianol and the like, has the effects of better improving peripheral blood circulation, improving the hypoxia tolerance of an organism under normal pressure and low pressure, accelerating the microcirculation blood flow rate, reducing the adhesion of sediments on the blood vessel wall, increasing the capillary network and the like, can promote the repair and regeneration of damaged tissue cells, has the effect of inhibiting the growth of tumors, and has the effect of inhibiting pseudomonas aeruginosa, escherichia coli, proteus and the like.
Furthermore, the radix curcumae extract has the main effects of promoting blood circulation, relieving pain, promoting qi circulation, relieving depression, cooling blood, clearing heart, benefiting gallbladder and removing jaundice, is used for treating depression of liver qi , distending pain of chest, abdomen and hypochondrium caused by internal blood stasis, irregular menstruation and the like, is used for damp-warm disease turbidity, phlegm-qi stasis, heart orifice blockage, stagnation of liver qi, heat transformation, blood forcing and recklessness and the like, and has the functions of cooling blood, removing blood stasis, relieving depression and the like.
Furthermore, the gynostemma pentaphylla extract contains more than 80 saponins, also contains rich micromolecular polysaccharide, more than 18 free amino acids, rich vitamins, more than 23 macro and trace elements, particularly boron, magnesium, manganese, zinc, molybdenum, selenium, copper and the like, and rich bioflavonoids and the like, and has the specific effects of: (1) lowering blood pressure, blood lipid and blood sugar; (2) preventing arteriosclerosis, inhibiting thrombosis, and treating cardiovascular diseases; (3) tranquilizing, antiaging, improving mental activity, and improving brain function; (4) activating cell, inhibiting obesity, invigorating spleen and stomach, relieving fatigue, tranquilizing, hypnotizing, and resisting stress; (5) anticancer, has effects of inhibiting cancer cell growth and metastasis, enhancing lymphocyte activity in blood, and enhancing immunity; (6) can eliminate the toxic and side effects of hormone medicines; (7) resisting ulcer, inhibiting ulcer and swelling, and treating constipation; therefore, the gynostemma pentaphylla has a good effect of eliminating hypertension, hyperglycemia and hyperlipidemia.
The invention has the beneficial effects that:
the invention can effectively remove blood stasis and activate blood, disperse aggregated red blood cells, remove garbage and dirt adhered to the vessel wall, dissolve and remove toxin, dredge the blood vessel, protect the cell membrane from oxidation, has extremely obvious dietotherapy effect and simultaneously reduces the occurrence of serious cardiovascular and cerebrovascular diseases through the synergistic action of a plurality of flavonoids, polyphenols, saponins and other compounds in the medicinal diet and a plurality of functional enzymes.
Detailed Description
The preparation method of the compound medicinal diet for reducing high blood pressure, high blood sugar and the process thereof comprise the following steps:
step 1: taking 0.8g of chrysanthemum extract, 0.4g of angelica extract, 0.5g of polygonatum extract, 2g of green tea extract, 0.8g of wolfberry extract, 0.4g of salvia extract, 0.3g of curcuma aromatica extract and 0.8g of gynostemma pentaphylla extract, mixing uniformly, and putting all the components into a stainless steel granulator for later use;
step 2: putting 1g of the mixed powder and 30mg of SOD into a 100ml triangular flask, injecting 3ml of magnetized water with the temperature of 40 ℃, fully stirring uniformly, and putting into an ultrasonic oscillator with the temperature of-40 HZ for ultrasonic oscillation for 20 minutes;
and step 3: pouring the mixed liquid medicine after ultrasonic oscillation into a small-sized sprayer, starting a granulator, spraying inwards while rotating, stopping the machine when the liquid medicine is sprayed out and the mixed extract medicinal powder is irregularly granular, taking out, and drying in a constant-temperature drying oven at 40 ℃;
and 4, step 4: taking out the dried granules when the water content is below 3%, cooling, filling 2g of the dried granules into each bag, and vacuum sealing to obtain the medicated food for reducing blood fat, blood pressure and cholesterol.
In this embodiment, the chrysanthemum extract, the angelica extract, the polygonatum extract, the green tea extract, the wolfberry extract, the salvia miltiorrhiza extract, the curcuma aromatica extract and the gynostemma pentaphylla extract in step 1 are all aqueous extracts.
In this example, the ratio of the raw materials to the extract in each extract in step 1 was 50: 1.
In this embodiment, the SOD in step 2 is a functional enzyme extracted from corn by a pure physical process, and its main characteristics are: SOD belongs to copper zinc type (cu, zn-SOD), is a water-soluble protease, the molecular weight is about 32KD, the half-life period is 72 hours, dry for 36 months at normal temperature, basically non-inactivation, the activity is 3000IU/mg, white powder, SOD has stronger ability of resisting hydrolysis of pepsin and trypsin, its super-strong activity has super-ordinary scavenging action to superoxide anion free radical and various toxins in human body, has extremely important function in preventing the oxidation of oxygen free radical to normal cell, resisting radiation damage and reducing cell variation and cell transformation cancer of variant cell.
In the embodiment, the chrysanthemum extract has the effects of dispelling wind, dissipating heat, detoxifying and improving eyesight, is used for treating conjunctival congestion, swelling and pain caused by wind heat of liver channels or hyperactivity of liver fire, blurred vision of two eyes, lacrimation caused by wind, and dizziness caused by liver wind, disturbance and hyperactivity of liver yang, and has a good inhibition effect on staphylococcus, streptococcus, pseudomonas aeruginosa, dysentery bacillus and other pathogenic bacteria, and particularly has an outstanding antipyretic and antihypertensive effect; the angelica extract has the effects of enriching blood, regulating menstruation, promoting blood circulation, relieving pain, relaxing bowel, treating dizziness, dim eyesight, palpitation, fatigue and weakness caused by blood deficiency and blood deficiency, treating irregular menstruation caused by blood deficiency, treating abdominal pain, blood stasis pain, arthralgia and numbness caused by blood deficiency, treating constipation caused by blood deficiency and the like, has the functions of breaking blood, promoting blood circulation and nourishing blood, and has the functions of easing pain, calming, protecting liver and preventing reduction of glycogen; the polygonatum extract has the effects of nourishing yin, moistening lung, promoting fluid production and nourishing stomach, is used for dry throat, thirst and cough caused by dryness heat of lung and stomach, is used for body fluid deficiency caused by heat injury of stomach yin and the like, and has a better improvement effect on myocardial ischemia.
In the embodiment, the green tea extract contains catechin, tea polyphenol, tea pigment, vitamins such as VC and VP and a plurality of mineral compositions, the vitamins and the catechin in the green tea can effectively enhance the flexibility and the elasticity of blood vessels, have the effects of resisting platelet aggregation, promoting fibrinolysis and lowering blood pressure, are particularly beneficial to preventing and treating cardiovascular and cerebrovascular diseases, have the effects of resisting oxidation, resisting radiation and improving immunity, have a definite anti-cancer and cancer-prevention effect, the tea polyphenol has the effects of preventing caries and strengthening teeth, small molecular compounds in the tea pigment have the effects of dissolving fat, low-density cholesterol and triglyceride in blood and preventing the accumulation of fat in liver, caffeine and small molecular aromatic substances in the tea have the excitation effect, can promote the strengthening of brain heartbeat, quickening blood flow, increasing digestive juice and enhancing the urine filtration function of glomeruli, also has antiallergic, antibacterial, antiviral, toxic substance removing, and halitosis eliminating effects, which is the main reason for reducing hypertension, hyperlipidemia and hyperglycemia by using various compounds in green tea.
In the embodiment, the wolfberry fruit extract has the effects of nourishing liver and kidney, improving eyesight and moistening lung, is used for dizziness, blurred vision, soreness and weakness of waist and knees, spermatorrhea, diabetes and the like caused by liver-kidney yin deficiency, is used for cough due to yin deficiency, little phlegm or no phlegm and the like, contains carotene, vitamin B, B, C, linoleic acid and the like, has the effect of reducing blood sugar, can inhibit fat deposition in liver cells and promote liver cell regeneration, and also has the effect of reducing blood cholesterol.
In the embodiment, the salvia miltiorrhiza extract has the effects of promoting blood circulation to remove blood stasis, cooling blood to relieve pain, nourishing blood to calm the nerves, is used for blood stasis amenorrhea and postpartum blood stasis and abdominal distending pain, is used for sore and carbuncle gall, local swelling and fever patients caused by excessive heat toxin, is used for high fever, dysphoria or macula and the like caused by warm diseases and heat entering nutrient blood, has slightly cold property and blood stasis removing effect which is greater than that of blood enriching, can remove blood stasis to promote tissue regeneration, has blood enriching effect which is not as good as that of angelica sinensis, contains tanshinone A, tanshinone B, tanshinone C, tanshinone and the like, has better effects of improving peripheral blood circulation, improving anoxia resistance of organisms under normal pressure and low pressure conditions, accelerating microcirculation blood flow rate, reducing adhesion of sediments on blood vessel walls, increasing capillary networks and the like, can promote repair and regeneration of damaged tissue cells, has the effect of inhibiting tumor growth, and has the effects of pseudomonas aeruginosa, escherichia coli, bacillus coli and the like, Bacillus proteus, etc.
In the embodiment, the radix curcumae extract has the main effects of promoting blood circulation, relieving pain, promoting qi circulation, relieving depression, cooling blood, clearing heart, benefiting gallbladder and removing jaundice, is used for treating depression of liver qi , distending pain of chest, abdomen and hypochondrium caused by internal blood stasis, irregular menstruation and the like, is used for damp-warm disease turbidity, phlegm-qi stasis, heart orifice blockage, stagnation of liver qi, heat transformation, blood forcing and recklessly flow and the like, and has the functions of cooling blood, removing blood stasis, moving blood and relieving depression.
In the embodiment, the gynostemma pentaphylla extract contains more than 80 saponins, also contains rich micromolecular polysaccharide, more than 18 free amino acids, rich vitamins, more than 23 macro and trace elements, particularly boron, magnesium, manganese, zinc, molybdenum, selenium, copper and the like, and rich bioflavonoids and the like, and has the specific effects of: (1) lowering blood pressure, blood lipid and blood sugar; (2) preventing arteriosclerosis, inhibiting thrombosis, and treating cardiovascular diseases; (3) tranquilizing, antiaging, improving mental activity, and improving brain function; (4) activating cell, inhibiting obesity, invigorating spleen and stomach, relieving fatigue, tranquilizing, hypnotizing, and resisting stress; (5) anticancer, has effects of inhibiting cancer cell growth and metastasis, enhancing lymphocyte activity in blood, and enhancing immunity; (6) can eliminate the toxic and side effects of hormone medicines; (7) resisting ulcer, inhibiting ulcer and swelling, and treating constipation; therefore, the gynostemma pentaphylla has a good effect of eliminating hypertension, hyperglycemia and hyperlipidemia.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (4)
1. The preparation method and the process of the compound medicinal diet for reducing high blood pressure, high blood sugar and high blood sugar are characterized in that: it comprises the following steps:
step 1: taking 0.8g of chrysanthemum extract, 0.4g of angelica extract, 0.5g of polygonatum extract, 2g of green tea extract, 0.8g of wolfberry extract, 0.4g of salvia extract, 0.3g of curcuma aromatica extract and 0.8g of gynostemma pentaphylla extract, mixing uniformly, and putting all the components into a stainless steel granulator for later use;
step 2: putting 1g of the mixed powder and 30mg of SOD into a 100ml triangular flask, injecting 3ml of magnetized water with the temperature of 40 ℃, fully stirring uniformly, and putting into an ultrasonic oscillator with the temperature of-40 HZ for ultrasonic oscillation for 20 minutes;
and step 3: pouring the mixed liquid medicine after ultrasonic oscillation into a small-sized sprayer, starting a granulator, spraying inwards while rotating, stopping the machine when the liquid medicine is sprayed out and the mixed extract medicinal powder is irregularly granular, taking out, and drying in a constant-temperature drying oven at 40 ℃;
and 4, step 4: taking out the dried granules when the water content is below 3%, cooling, filling 2g of the dried granules into each bag, and vacuum sealing to obtain the medicated food for reducing blood fat, blood pressure and cholesterol.
2. The preparation method and the process of the compound three-high reducing medicated diet as claimed in claim 1, wherein the preparation method comprises the following steps: the chrysanthemum extract, the angelica extract, the polygonatum extract, the green tea extract, the wolfberry fruit extract, the salvia miltiorrhiza extract, the curcuma aromatica extract and the gynostemma pentaphylla extract in the step 1 are all aqueous extracts.
3. The preparation method and the process of the compound three-high reducing medicated diet as claimed in claim 1, wherein the preparation method comprises the following steps: the ratio of raw materials to the extract in each extract in the step 1 is 50: 1.
4. The preparation method and the process of the compound three-high reducing medicated diet as claimed in claim 1, wherein the preparation method comprises the following steps: the SOD in the step 2 is a functional enzyme extracted from corn by a pure physical process method.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110954950.8A CN113577249A (en) | 2021-08-19 | 2021-08-19 | Method and process for making compound medicinal food for reducing high blood pressure, high blood sugar and high blood sugar |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110954950.8A CN113577249A (en) | 2021-08-19 | 2021-08-19 | Method and process for making compound medicinal food for reducing high blood pressure, high blood sugar and high blood sugar |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113577249A true CN113577249A (en) | 2021-11-02 |
Family
ID=78238467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110954950.8A Pending CN113577249A (en) | 2021-08-19 | 2021-08-19 | Method and process for making compound medicinal food for reducing high blood pressure, high blood sugar and high blood sugar |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113577249A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114404552A (en) * | 2022-02-28 | 2022-04-29 | 江苏陕东生物科技集团有限公司 | Application of compound paclitaxel in preparation of anti-hypertension, hyperglycemia and hyperlipidemia traditional Chinese medicine and tablet formulas |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103300366A (en) * | 2013-06-05 | 2013-09-18 | 林树芳 | Blood sugar reduction medicated food capable of eliminating sugar poison and discharging medicine poison |
| CN103300365A (en) * | 2013-06-05 | 2013-09-18 | 林树芳 | Medicated food with functions of reducing blood fat, blood pressure and cholesterol |
| CN105076582A (en) * | 2014-05-09 | 2015-11-25 | 李启辉 | Aboriginal traditional Chinese herbal mixed tea capable of reducing blood pressure and blood fat and preparation method thereof |
-
2021
- 2021-08-19 CN CN202110954950.8A patent/CN113577249A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103300366A (en) * | 2013-06-05 | 2013-09-18 | 林树芳 | Blood sugar reduction medicated food capable of eliminating sugar poison and discharging medicine poison |
| CN103300365A (en) * | 2013-06-05 | 2013-09-18 | 林树芳 | Medicated food with functions of reducing blood fat, blood pressure and cholesterol |
| CN105076582A (en) * | 2014-05-09 | 2015-11-25 | 李启辉 | Aboriginal traditional Chinese herbal mixed tea capable of reducing blood pressure and blood fat and preparation method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114404552A (en) * | 2022-02-28 | 2022-04-29 | 江苏陕东生物科技集团有限公司 | Application of compound paclitaxel in preparation of anti-hypertension, hyperglycemia and hyperlipidemia traditional Chinese medicine and tablet formulas |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103536793A (en) | Composition with functions of clearing away heat and toxic materials and removing fire as well as preparation method thereof | |
| CN104642646A (en) | Beauty tea and preparation method thereof | |
| CN113577249A (en) | Method and process for making compound medicinal food for reducing high blood pressure, high blood sugar and high blood sugar | |
| CN103156014A (en) | Black tea beverage having effects of enriching blood and tonifying qi and preparation method thereof | |
| CN104888007A (en) | Ferment mouthrinse for treating dental ulcer and preparation method thereof | |
| CN109528966B (en) | Health wine and preparation method thereof | |
| CN103300365A (en) | Medicated food with functions of reducing blood fat, blood pressure and cholesterol | |
| CN101385536A (en) | Natural plant hypoglycemic effervescent beverages | |
| CN111249410A (en) | Medicated diet beverage for protecting liver, removing toxicity, discharging fat, preventing and treating liver injury and recovering liver function | |
| CN113750187A (en) | A formula containing Garcinia cambogia and Hibiscus sabdariffa for preventing and treating renal calculus | |
| CN113663023A (en) | A Ganoderma composition for treating hypertension and its preparation method | |
| CN112690382A (en) | Beverage capable of clearing away heat and toxic materials | |
| CN112294925A (en) | A medicine for treating gout, gastropathy and constipation, and its preparation method | |
| CN101972351A (en) | Traditional Chinese medicine for treating thrombocytopenia and Henoch-Schonlein purpura | |
| CN112136993A (en) | Medicinal and edible fermented beverage and preparation method thereof | |
| CN104922449A (en) | Traditional Chinese medicine disinfection solution and preparation method thereof | |
| CN110771894A (en) | Pilose antler oral liquid and preparation method thereof | |
| CN108939007A (en) | A kind of biofermentation preparation and its preparation method and application | |
| CN102145085A (en) | Traditional Chinese medicinal health-care tea for preventing and treating hyperlipemia | |
| CN101199765A (en) | Medicament for treating stomach disease | |
| CN1839965A (en) | Preparation method of stomach-tonifying food-digesting oral liquid containing micro pine pollen, fig,haw, chickens gizzard-membrane, 'houtou'mushroom etc. | |
| CN1205946C (en) | Formulation for clearing away heat and toxic material | |
| CN104970134A (en) | Purely natural slimming tea beverage and preparation method thereof | |
| CN105395827A (en) | Method for preparing composition with function of reducing blood fat | |
| CN117797196A (en) | Capsule for treating hypertension and coronary heart disease and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211102 |
|
| RJ01 | Rejection of invention patent application after publication |